COMMUNIQUÉS West-GlobeNewswire

ERYTECH tiendra un webcast le 7 mai 2019 à l’occasion de ses résultats du premier trimestre 2019
02/05/2019
LYON, France, 02 mai 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans les [...]
Repligen to Report First Quarter 2019 Financial Results
02/05/2019
Webcast and Conference Call to Be Held Thursday, May 9, 2019 at 8:30 a.m. EDT WALTHAM, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first [...]
Teligent, Inc. to Hold Conference Call for First Quarter 2019 Results on Monday May 6th, 2019
02/05/2019
BUENA, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday May 6 th [...]
Biocartis Group NV: BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024
02/05/2019
PRESS RELEASE : REGULATED INFORMATION - INSIDE INFORMATION 2 May 2019, 19:30 CEST BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024 Mechelen, Belgium, 2 May 2019 - [...]
XBiotech annonce l'achèvement du recrutement et des résultats positifs pour le bermekimab dans une étude sur le cancer pancréatique
02/05/2019
XBiotech et le Centre médical Cedars-Sinai évaluent le bermekimab en combinaison avec la chimiothérapie chez des patients atteints du cancer pancréatique et de cachexie AUSTIN, Texas, 02 mai 2019 (GLOBE NEWSWIRE) -- [...]
Agios Announces FDA Approval of Supplemental New Drug Application (sNDA) for TIBSOVO® as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy
02/05/2019
– TIBSOVO ® is the First and Only Therapy Approved for Newly Diagnosed AML Patients with an IDH1 Mutation who are Ineligible for Intensive Chemotherapy – – sNDA Approval Based on 28 Newly Diagnosed Patients from Phase 1 [...]
NSS Labs Appoints New Chief Executive Officer
02/05/2019
AUSTIN, Texas, May 02, 2019 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent cybersecurity product testing, today announced that Jason Brvenik has been named Chief Executive Officer [...]
PCI Biotech: Successful clinical translation of the fimaVacc technology
02/05/2019
Oslo (Norway), 2 May 2019 – PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced that the final immune response [...]
ORION CORPORATION: ACQUISITION OF OWN SHARES 02.05.2019
02/05/2019
Orion Corporation NOTIFICATION 02.05.2019 at 19:13 ORION CORPORATION: ACQUISITION OF OWN SHARES 02.05.2019 Date 02.05.2019 Exchange transaction Buy Share class ORNBV Amount 46,000 Average price/share 29.4115 EUR Highest [...]
Nicox: Number of voting rights 30 April 2019
02/05/2019
Nicox SA Société anonyme with a registered capital of € 29,909,120 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On May 2, 2019, MONTHLY PUBLICATION OF THE [...]
Nicox : Droits de vote 30 avril 2019
02/05/2019
Nicox SA Société anonyme au capital de 29 909 120 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 2 mai 2019, PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS [...]
Information on total number of voting rights and shares composing the share capital as at April 30th, 2019
02/05/2019
Paris, May 2 nd , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives, [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2019
02/05/2019
Paris, le 2 mai 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de façon [...]
Nexstim Plc: The final outcome of the subscription rights issue of Nexstim Plc
02/05/2019
Company announcement, Helsinki, 2 May 2019 at 6.30 PM Nexstim Plc: The final outcome of the subscription rights issue of Nexstim Plc NOT TO BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY TO THE UNITED STATES OF [...]
Reserveage Launches Sugar-Free Collagen Candy in Tasty Candy-Style Stick
02/05/2019
BOCA RATON, Fla., May 02, 2019 (GLOBE NEWSWIRE) -- Reserveage Nutrition makes collagen supplementation easy and tasty with the launch of Collagen Candy, a powdered treat that dissolves on the tongue and will remind you [...]
LHC Group and Capital Region Medical Center announce purchase and expansion of joint venture partnership
02/05/2019
LAFAYETTE, La. and JEFFERSON CITY, Mo., May 02, 2019 (GLOBE NEWSWIRE) -- Joint venture partners LHC Group, Inc. (NASDAQ: LHCG) and Capital Region Medical Center (CRMC) today announced an agreement to purchase from SSM [...]
CB2 Insights Expands Board with Teladoc Executive Marc Adelson, Appoints David Danziger as Chairman and Adopts Advance Notice Bylaw
02/05/2019
Leading Telemedicine Firm’s Deputy Chief Legal Officer Joins Board Increasing Healthcare Technology Expertise TORONTO, May 02, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII) (OTCQB:CBTOF) a [...]
FeraMAX® Named #1 by Canadian Physicians and Pharmacists for Fourth Consecutive Year
02/05/2019
TORONTO, May 02, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that for the fourth consecutive year, FeraMAX ® has been named the #1 recommended iron supplement brand in a [...]
Eloxx Pharmaceuticals Presents Positive New Data at the Association for Research in Vision and Ophthalmology “ARVO” 2019 Annual Meeting
02/05/2019
Eloxx is evaluating several of its eukaryotic ribosomal selective glycoside (ERSG) molecules in IND-enabling studies for use in the treatment of inherited retinal diseases with an initial focus on Usher Syndrome [...]

Pages